Nov 09, 2017 Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
Sep 27, 2017 Avenue Therapeutics Announces Dosing of First Patient in Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain
Aug 15, 2017 Avenue Therapeutics Announces Appointment of Joseph Vazzano as Vice President of Finance and Corporate Controller (principal financial and accounting officer)
Aug 11, 2017 Avenue Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
